Antigenic distance measurements for seasonal influenza vaccine selection.

Influenza vaccination is one of the major options to counteract the effects of influenza diseases. Selection of an effective vaccine strain is the key to the success of an effective vaccination program since vaccine protection can only be achieved when the selected influenza vaccine strain matches the antigenic variants causing future outbreaks. Identification of an antigenic variant is the first step to determine whether vaccine strain needs to be updated. Antigenic distance derived from immunological assays, such as hemagglutination inhibition, is commonly used to measure the antigenic closeness between circulating strains and the current influenza vaccine strain. Thus, consensus on an explicit and robust antigenic distance measurement is critical in influenza surveillance. Based on the current seasonal influenza surveillance procedure, we propose and compare three antigenic distance measurements, including Average antigenic distance (A-distance), Mutual antigenic distance (M-distance), and Largest antigenic distance (L-distance). With the assistance of influenza antigenic cartography, our simulation results demonstrated that M-distance is a robust influenza antigenic distance measurement. Experimental results on both simulation and seasonal influenza surveillance data demonstrate that M-distance can be effectively utilized in influenza vaccine strain selection.

[1]  A. Monto,et al.  Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test , 1981, Journal of clinical microbiology.

[2]  Oie,et al.  Toward a Unified Nomenclature System for Highly Pathogenic Avian Influenza Virus (H5N1) , 2008, Emerging infectious diseases.

[3]  K. Eichmann,et al.  INFLUENCE OF GENETIC FACTORS ON THE MAGNITUDE AND THE HETEROGENEITY OF THE IMMUNE RESPONSE IN THE RABBIT , 1971, The Journal of experimental medicine.

[4]  G L Ada,et al.  Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.

[5]  R. Webster,et al.  Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. , 1976, The Journal of infectious diseases.

[6]  Tong Zhang,et al.  Concepts and applications for influenza antigenic cartography. , 2011, Influenza and other respiratory viruses.

[7]  C W Potter,et al.  Determinants of immunity to influenza infection in man. , 1979, British medical bulletin.

[8]  Ron A M Fouchier,et al.  Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. , 2008, Vaccine.

[9]  Keiji Fukuda,et al.  Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season. , 2010, Vaccine.

[10]  G. Oster,et al.  Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination. , 1979, Journal of theoretical biology.

[11]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[12]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[13]  A. Fomsgaard,et al.  The evolution of human influenza A viruses from 1999 to 2006: A complete genome study , 2008, Virology Journal.

[14]  M. Fine,et al.  The Cost of Treating Patients with Community-Acquired Pneumonia , 1999 .

[15]  T. Cate,et al.  Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement , 1980, Journal of clinical microbiology.

[16]  Cecile Viboud,et al.  Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus , 2006, Biology Direct.

[17]  S O Mast REPLY TO HOLMES'S CRITICISM OF "LIGHT AND THE BEHAVIOR OF ORGANISMS". , 1912, Science.

[18]  Zhipeng Cai,et al.  A Computational Framework for Influenza Antigenic Cartography , 2010, PLoS Comput. Biol..

[19]  A. Kumar,et al.  Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans , 2010 .

[20]  A S Perelson,et al.  Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Erin Burns,et al.  Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. , 2010, MMWR. Morbidity and mortality weekly report.

[22]  R. Webster,et al.  DISQUISITIONS ON ORIGINAL ANTIGENIC SIN : II. PROOF IN LOWER CREATURES , 1966 .

[23]  L. Simonsen,et al.  The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.

[24]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[25]  W. Fitch,et al.  Predicting the evolution of human influenza A. , 1999, Science.

[26]  B. Cowling,et al.  Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. , 2010, Clinical Infectious Diseases.

[27]  Alan S. Perelson,et al.  Modeling the effects of updating the influenza vaccine on the efficacy of repeated vaccination , 2000 .

[28]  R Farber,et al.  The geometry of shape space: application to influenza. , 2001, Journal of theoretical biology.